Novo Nordisk (NVO) downgraded to Hold by HSBC amid growth concerns, GLP-1 market challenges, and revised 2025-2026 earnings ...

Explore this week's standout equity moves including Next's guidance upgrades, Novo Nordisk's warning and Fresnillo's ...

Danish leader will face a challenging landscape among competitors ...

The unusually intense rainfall over these weeks has pushed July close to ranking among the ten wettest months on record since 1874, writes DR. During the month coming to an end today, the country has ...

Shares of Danish drugmaker Novo Nordisk (NVO) traded 8% lower on Wednesday afternoon after the company slashed its full-year ...

Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session ...

Hit by rising medical care costs and squeezed by government changes, the health care conglomerate acknowledges “pricing and operational mistakes” affected its bottom line and has outlined steps to ...

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Novo Nordisk's technical chart is displaying a largely bearish trend amid a profit warning tied to its blockbuster obesity ...

The U.K. will recognize a Palestinian state if there’s no cease-fire. Britain’s prime minister, Keir Starmer, announced ...

Shares of Hims & Hers, which has clashed with Novo Nordisk over its sales of compounded glucagon-like peptide inhibitors, rose slightly in the wake of the report, and have more than doubled in value ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...